Primary lesion: de-novo un-altered lesion Secondary lesion: evolution of 1' lesion
Profile | <1cm diameter | >1cm diameter |
---|---|---|
Flat | Macule | Patch |
Raised superficial | Papule | Plaque |
Deep palpable | Nodule | Tumor |
Fluid filled | Vesicle | Bulla |
Often hinges on history and physical exam. Frequently however, biopsy may be done to confirm or establish a diagnosis.
Potency | Relative Strength | Generics | Brand | Usage |
---|---|---|---|---|
Weak | x1 | hydrocortisone–2.5% (1% and 0.5% available over-the-counter) | Emo cort | Intertriginous areas, children, face, thin skin |
Moderate | x3 | betamethasone-valerate-0.1%; hydrocortisone 17-valerate-0.2%; desonide; mometasone furoate | Betaderm; Hydroval; Tridesilon; Elocom | Arm, leg, trunk |
Potent | x6 | amcinonide | Cyclocort | Body |
Very potent | x9 | betamethasone dipropionate-0.05%; fluocinonide-0.05%; halcinonide | Diprosone; Lindex; Lyderm; Halog | Palms and soles |
Extreme | x12 | Clobetasol propionate-0.05% (most potent); betamethasone-dipropionate ointment; halobetasol proprionate-0.05% | Dermovate; diprolene; ultravate | Palms and soles |